Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
NAMS
Fundamentals

Newamsterdam Pharma Co N.v.

NAMS

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

2.98M
▼-9.79M▼-76.68%
3 Months Change

Assets

471.10M
▼-60.49M▼-11.38%
6 Months Change

Liabilities

41.05M
▼-66.07M▼-61.68%
3 Months Change

Free Cash Flow

-36.48M
▲18.50M▲33.65%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2024-10-18
Form 8-K
ID: 0001193125-24-239687
2024-08-09
Form 8-K
ID: 0001193125-24-197971
2024-08-07
Form 10-Q
ID: 0000950170-24-092281
2024-08-07
Form 8-K
ID: 0000950170-24-092279
2024-07-29
Form 8-K
ID: 0001193125-24-186747
2024-07-18
Form 8-K
ID: 0001193125-24-180754
2024-06-11
Form 8-K
ID: 0001193125-24-158751
2024-06-07
Form 8-K
ID: 0001193125-24-157374
2024-05-09
Form 8-K
ID: 0000950170-24-056292
2024-05-08
Form 10-Q
ID: 0000950170-24-055767